AZD7442 (tixagevimab/cilgavimab)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD7442 (tixagevimab/cilgavimab), covering 2024-07-30 to 2025-04-18. Get the full timeline:
Most recent: Clinical Trial Update: AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics [Phase 1]